D. S. Postma (Groningen, The Netherlands), G. Anderson (Parkville, Australia)
LATE-BREAKING ABSTRACT: IRF3 is required for the induction of allergic airway inflammation by lung dendritic cells in a mouse model of house dust mite-induced atopic asthma
T. M. Marichal, D. B. Bedoret, S. G. Goeriely, M. G. Goldman, F. B. Bureau, C. D. Desmet (Liège, Gosselies, Belgium)
|  |
LATE-BREAKING ABSTRACT: The role of FcRn in the allergic airway inflammation
K. N. Nakata, K. K. Kobayashi, Y. I. Ishikawa, S. O. Okamoto, M. Y. Yamamoto, Y. F. Funada, Y. K. Kotani, M. Y. Yoshida, Y. N. Nishimura (Kobe, Japan)
|  |
LATE-BREAKING ABSTRACT: The role of prostacyclin in endothelial – eosinophil interaction
V. K. Konya, E. M. S. Sturm, A. H. Heinemann (Graz, Austria)
| |
Measurement of nasal resistance and response in mice
J. Xie, Q. Zhang, K. Lai, N. Zhong (Guangzhou, China)
| |
Evaluation of a GR-ELISA for quantitative determination of glucocorticoid receptor activity in adherent cells and blood leukocytes
M. Gencay, J. J. Rüdiger, M. Tamm, M. Roth (Basel, Switzerland)
| |
PF-00610355 – an inhaled β2 adrenoceptor agonist with superior potency and duration of action (DoA) to salmeterol in the conscious dog model of bronchoconstriction
K. Wright, T. Davies, N. Clarke, M. Yeadon, C. Perros-Huguet (Sandwich, United Kingdom)
| |
Effects of lipopolysaccharide (LPS) from E. coli 0111:B4 on electrical field stimulation (EFS) response in human isolated bronchi
L. Calzetta, M. G. Matera, M. Cazzola (London, United Kingdom; Naples, Rome, Italy)
| |
Changes in susceptibility to antibiotics staphylococcus aureus under effect of dissolved ozone
I. Belyanin, E. Shmelev (Moscow, Russian Federation)
| |
Activation of different airway ion transport pathways after toluene diisocyanate (tdi) exposure
E. Piskorska, I. Holynska, P. Kaczorowski, E. Kopczynska, M. Lampka, P. Smuszkiewicz, I. Trojanowska, T. Tyrakowski (Bydgoszcz, Poznan, Poland)
| |
Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD
J. Knobloch, B. Sibbing, D. Jungck, H. Hag, K. Urban, J. Strauch, A. Koch (Cologne, Germany)
| |
Inhibitory effect of Crocus sativus (saffron) on histamine (H1) receptors of guinea pig tracheal chains
M. H. Bboskabady, M. Ghasemzadeh Rahbardar (Mashhad, Islamic Republic Of Iran)
| |
Effects of salbutamol enantiomers on equine isolated bronchial airways
L. Calzetta, M. G. Matera, M. Cazzola (London, United Kingdom; Naples, Rome, Italy)
| |
The in vitro biology of PF-00610355 – a novel β2 adrenoceptor agonist with a long duration of action
M. Coghlan, C. Jones, S. Summerhill, S. Patel, N. Clarke, M. Trevethick, M. Yeadon, C. Perros-Huguet (Sandwich, United Kingdom)
| |
The inhibitory effect of formoterol and salmeterol on the IP-10 (CXCL10) in bronchial epithelial cells
S. N. Yang, Y. T. Chu (Kaohsiung, Taiwan)
| |
Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication
M. Muraki, S. Yamagata, Y. Ikeda, A. Sano, R. Sato, T. Yamagata, H. Sano, T. Iwanaga, T. Miyara, K. Tomita, Y. Higashimoto, Y. Tohda (Osakasayama, Japan)
| |
Effect of inhaled corticosteroids depends on its particle size
Y. To, T. Takezawa, T. Arai, M. Sasaki, Y. Okada, N. Horita (Tokyo, Japan)
| |
Lung reactivity to a new hybrid piridin-phenothiazinic derivative in rats
C. Zamfir, C. C. Grigoras, A. Grigoras, E. Cojocaru, C. Lupusoru, E. Bicu (Iasi, Romania)
| |
Effects of aclidinium bromide on mucin muc5AC expression in human airway cells
M. Mata, J. Milara, E. Donet, A. Gavaldà, M. Miralpeix, J. Cortijo, E. J. Morcillo (Valencia, Barcelona, Spain)
| |